Show results for
Refine by
Macular Edema Equipment & Supplies
15 equipment items found
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC399 is our proprietary BioSeizer formulation of dexamethasone sodium phosphate (DSP), intended as an intravitreal, or in-eye, injection for the treatment of macular edema due to retinal vein occlusion. TLC399 in preclinical models has been shown to provide therapeutic levels of DSP in the eye for at least six months after a single administration. A Phase I/II ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
FIRST commercial product developed by Clearside; FIRST approved therapeutic delivered into the suprachoroidal space; FIRST therapy for macular edema associated with uveitis; FIRST uveitis trial using visual acuity change as a primary endpoint (Phase 3 ...
Manufactured by:Digital Diagnostics Inc. based inCoralville, IOWA (USA)
IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion ...
Manufactured by:Notal Vision, Inc. based inManassas, VIRGINIA (USA)
The Notal OCT Analyzer (NOATM) is a computational image analysis algorithm designed to provide automated detection of fluid in exudative retinal diseases including wet Age-Related Macular Degeneration, macular edema, and retinal vein occlusions. NOA uses a machine learning algorithm and image recognition computational technique to distinguish ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Ketorolac (RS37619) is a non-steroidal anti-inflammatory drug (NSAID), acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2. Ketorolac tromethamine is used as 0.5% ophthalmic solution for the research of allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Ketorolac (RS37619) is a non-steroidal anti-inflammatory drug (NSAID), acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2. Ketorolac tromethamine is used as 0.5% ophthalmic solution for the research of allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain. ...
by:UNITY Biotechnology based inSouth San Francisco, CALIFORNIA (USA)
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX1325 is designed to selectively eliminate the senescent cells accumulating in diseased blood vessels of the eye. This ...
Manufactured by:Lutronic Vision based inBillerica, MASSACHUSETTS (USA)
R:GEN is the only retinal laser proven to deliver safe, efficacious and precise targeting of Retinal Pigment Epithelium (RPE) cells. R:GEN’s proprietary Real-Time Feedback, Dual Dosimetry, and Auto Ramp-up technologies ensure precise targeting of RPE cells without damage to ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
As part of our small molecule program, we are evaluating the suprachoroidal administration of an integrin inhibitor suspension. Integrins play a role in pathologic processes, such as inflammation, angiogenesis and fibrosis. Suprachoroidal delivery of an integrin inhibitor suspension could provide targeting, compartmentalization and durability advantages over topical or intravitreal delivery, ...
Manufactured by:IPG Photonics Corporation based inMarlborough, MASSACHUSETTS (USA)
Historically, ophthalmology was the first medical field where lasers have found an application. Over more than five decades, use of lasers in ophthalmology has successfully shown effective and safe results in treating various eye conditions. Whether lasers are used to correct vision or repair damage due to degenerative diseases dictates optimal laser type, wavelength, and pulse length. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Nepafenac (AHR 9434; AL 6515; Nevanac) is a COX-2 inhibitor and the original drug of ...
Manufactured by:DSM based inHeerlen, NETHERLANDS
Discover our implantable drug delivery systems made of bioresorbable polymers that release precise quantities of therapeutic agents gradually over time. DSM is a global leader in biomedical materials science – experience that we are now using to create advanced sustained release drug products as implantable or injectable delivery forms. DSM offers two proprietary, highly versatile polymer ...